The Study of Infliximab (CMAB008 and Remicade) in Healthy Subjects to Compare the PK and Safety
Clinical trial NCT04779892 · COMPLETED
Trial details
- NCT number
- NCT04779892
- Sponsor
- Taizhou Mabtech Pharmaceutical Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-01
- Primary completion
- 2020-06-15
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.